Related Experiment Video
Updated: Aug 29, 2025

09:16
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
Amplification of RUNX1 in a Patient With AML
Rodrigo Hurtado1, Stalin Tello2, Juan Juarez2
1The International Circle of Genetics Studies, Los Angeles, CA.
Journal of the Association of Genetic Technologists
|September 7, 2022
Summary
This case study details a rare instance of acute myeloid leukemia (AML) with RUNX1 amplification in a 60-year-old patient. This genetic abnormality, often linked to poor prognosis, highlights the complexity of AML.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a complex blood cancer with diverse genetic underpinnings.
- RUNX1 amplification is a rare genetic event in AML, with limited reported cases, often associated with therapy-related AML and a poor prognosis.
Purpose of the Study:
- To describe a rare case of AML with RUNX1 amplification.
- To highlight the clinical presentation and diagnostic findings of this unusual AML subtype.
Main Methods:
- Case report of a 60-year-old patient presenting with symptoms of AML.
- Diagnostic workup included complete blood count, bone marrow examination, flow cytometry, chromosome analysis, and FISH studies.
- FISH analysis confirmed amplification of RUNX1, with five copies detected.
Main Results:
- The patient presented with severe anemia, thrombocytopenia, leukocytosis, and organomegaly.
- Bone marrow examination revealed 97% myeloid blasts.
- Genetic analysis identified isochromosome 21q and significant RUNX1 amplification.
Conclusions:
- RUNX1 amplification is an exceptionally rare finding in AML, particularly in non-therapy-related cases.
- This case underscores the importance of comprehensive genetic analysis in AML diagnosis and prognosis.
- Further research is needed to understand the implications of RUNX1 amplification in AML.
Related Concept Videos
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K

